Skip to Main Content U.S. Department of Energy
Economic Development Office

Tri-Cities Tech Business Update

February 2008 Issue

Agreement signed for new U.S. supply of medical isotope indium-111

In January, Advanced Medical Isotope Corporation of Kennewick, Wash. signed a five-year agreement with New-York-based Central Pharmaceutical Services, Inc. for the joint production and marketing of indium-111, an isotope used in specialized diagnostic imaging. By labeling indium-111 to antibodies and peptides that transport it to specific parts of the body, physicians can image colorectal cancer, prostrate cancer, and neuroendocrine tumors. Indium-111 also can be used to label white blood cells, platelets, and red blood cells for diagnostic purposes. Initial commercial quantities of indium-111 are expected in the second quarter of 2008. The company was featured in the fall 2007 issue of Mid-Columbian magazine.

Contact at (509) 736-4000.


News & Events

Programs & Resources

Share This

Share This!

Additional Information


Current Issue

Back Issues